Pfizer Asks FDA to Authorize COVID Vax for Kids Younger Than 5
The FDA has accepted Pfizer's application for a COVID-19 vaccine for children under 5, which clears the way for approval later this month.
Source: medscape.com
Page 2 - High Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from High Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In High Efficacy Today - Breaking & Trending Today
Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
Investegate announcements from BioNTech SE, Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
Source: investegate.co.uk
Moleculin Receives Allowance to Proceed with Phase 1/2 Study of Annamycin in Combination with Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...
Source: prnewswire.com
Moleculin Provides Annamycin AML Program Update and Outlines Next Steps to Advance Towards Late-Stage Development
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...
Source: prnewswire.com
Research Team Develops Anticoagulants With High Efficacy
Study explained how researchers developed thrombin inhibitors to be potent anticoagulants based on sequences of inhibitors of blood coagulation enzyme thrombin found in the tropical bont tick Amblyomma variegatum.
Source: medindia.net